A comprehensive view of Injectables / Infusions / IV Drips. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Logistic & Supply Chain Market Intelligence Service.
Dr. Reddy's Laboratories partners with Pharmazz, gaining exclusive rights to market and distribute first-in-class resuscitative agent Centhaquine in India, a drug to treat hypovolemic shock, under the brand name Lyfaquin
Published:
March 27, 2024
by Marketline - Deals
|
Novo Nordisk's diabetes treatment Awiqli gets positive CHMP opinion for adult use in Europe; the once-weekly basal insulin icodec shows improved blood sugar reduction and safety profile, becoming a potential preferred treatment for type 2 diabetes
Published:
March 26, 2024
by Contify Life Science News
|
Novartis Canada disagrees with CADTH's draft recommendations not to reimburse LEQVIO for hypercholesterolemia treatment in Canada; Novartis claims LEQVIO has aided over 178,000 patients, including 2,000 Canadians, since 2022
Published:
March 26, 2024
by Contify Life Science News
|
FDA grants Fast Track designation to J&J's nipocalimab injectable for FNAIT treatment, a potentially life-threatening condition affecting pregnant women's immune response to fetal platelets; it is the only therapy in clinical development for the disorder
Published:
March 26, 2024
by Janssen Pharmaceutical Companies
|
Amgen testing injectable weight loss drug MariTide that offers the potential of monthly administration; the drug appears promising in early trials in a market forecast to be worth up to US$100.0B by the end of the decade
Published:
March 25, 2024
by Baystreet US News Alerts
|
Ask us about our Logistic & Supply Chain market view